Department of Animal Sciences, Nutritional Sciences Graduate Program, School of Environmental and Biological Sciences, Rutgers, The State University of New Jersey New Brunswick, NJ, 08901, USA.
Department of Animal Sciences, Nutritional Sciences Graduate Program, School of Environmental and Biological Sciences, Rutgers, The State University of New Jersey New Brunswick, NJ, 08901, USA.
Pharmacol Biochem Behav. 2022 Feb;213:173329. doi: 10.1016/j.pbb.2022.173329. Epub 2022 Jan 8.
Interactions between obesity and opioid use are poorly understood. The objective of this study was to determine whether phenotypic differences in diet-induced weight gain altered morphine withdrawal responses. Male and female C57BL/6J mice were characterized as obese prone (OP) or obese resistant (OR) based on median split in body weights following exposure to high-fat diet (45% fat). After classification into OP or OR, all mice were fed a low-fat diet (10% fat) for the remainder of the study (≥5 weeks) to remain weight matched. Mice were treated with a 7-day escalating dosing scheme of morphine (20-100 mg/kg; IP) or saline and underwent a spontaneous withdrawal. Morphine-induced weight loss was restored by withdrawal day 7. On withdrawal day 8, male OP demonstrated less total time mobile in the open field test (OFT). In females, OR-morphine traveled less distance than OR-saline, and OR-morphine spent less time mobile compared with all other groups in the OFT. Female OP also increased time spent in the center of the apparatus, regardless of treatment. On withdrawal day 8, relative gene expression was measured by qPCR. For males, expression of dopamine beta-hydroxylase (dbh), alpha-adrenergic receptor 2 a (adra2a), and orexin receptor 1 (orx1) were increased in the locus coeruleus (LC) region of OP mice, regardless of treatment. In comparison, in females, dbh and adra2a were decreased in the LC region of OP mice, regardless of treatment. Also, in the LC region of females, OP-morphine had lower expression of alpha-adrenergic receptor 1 a (adra1a) than OR-morphine and OP-saline. In the hypothalamic paraventricular nucleus (PVN) of females, adra2a was increased in OP-morphine compared with OP-saline and OR-morphine. Our findings suggest morphine withdrawal responses and regional expression of noradrenergic-related genes are differentially influenced by weight gain propensity.
肥胖和阿片类药物使用之间的相互作用尚不清楚。本研究的目的是确定饮食诱导的体重增加的表型差异是否改变了吗啡戒断反应。根据暴露于高脂肪饮食(45%脂肪)后体重的中位数分割,雄性和雌性 C57BL/6J 小鼠被分为肥胖倾向(OP)或肥胖抵抗(OR)。分类为 OP 或 OR 后,所有小鼠均在研究的剩余时间(≥5 周)内喂食低脂肪饮食(10%脂肪)以保持体重匹配。小鼠接受为期 7 天的吗啡递增剂量方案(20-100mg/kg;IP)或生理盐水治疗,并经历自发戒断。吗啡诱导的体重减轻在戒断第 7 天得到恢复。在戒断第 8 天,雄性 OP 在旷场测试(OFT)中表现出更少的总移动时间。在雌性中,与 OR-生理盐水相比,OR-吗啡的行进距离较短,与 OFT 中的所有其他组相比,OR-吗啡的移动时间较少。OP 雌性无论治疗如何,还增加了在仪器中心的时间。在戒断第 8 天,通过 qPCR 测量相对基因表达。对于雄性,无论治疗如何,多巴胺β-羟化酶(dbh)、α-肾上腺素能受体 2a(adra2a)和食欲素受体 1(orx1)在 OP 小鼠的蓝斑(LC)区域的表达增加。相比之下,在雌性中,dbh 和 adra2a 在 OP 小鼠的 LC 区域的表达降低,无论治疗如何。此外,在雌性的 LC 区域,与 OR-吗啡和 OP-生理盐水相比,OP-吗啡的α-肾上腺素能受体 1a(adra1a)表达较低。在雌性的下丘脑室旁核(PVN)中,与 OP-生理盐水和 OR-吗啡相比,OP-吗啡的 adra2a 增加。我们的研究结果表明,吗啡戒断反应和去甲肾上腺素相关基因的区域表达受体重增加倾向的影响不同。